HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: R400013-JLR200v1 46/1/1    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Getz, G. S. Search for Related Content PubMed PubMed Citation Articles by Getz, G. S. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 46, 1-10, January 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology

Thematic Review

Thematic review series: The Immune System and Atherogenesis. Immune function in atherogenesis

Godfrey S. Getz¹

Department of Pathology, Biochemistry, and Molecular Biology, University of Chicago, Chicago, IL

¹ To whom correspondence should be addressed. e-mail: g-getz{at}uchicago.edu

In this overview to a new thematic series on the immune system and atherogenesis, I provide a very brief summary of current conceptions of atherogenesis, of the innate and adaptive immune systems, and of the participation of the latter in atherogenesis, with particular emphasis on studies of the involvement of the immune system in atherosclerosis reported in the last 2 years. This is followed by a short outline of the eight reviews that will make up this thematic series.

The overview is concluded with some caveats that should be considered in the analysis of atherosclerosis in experimental animals.

Abbreviations: apoE, apolipoprotein E; CD40L, CD40 ligand; CRP, C-reactive protein; dn, dominant negative; IL, interleukin; MHC, major histocompatibility complex; NF-B, nuclear factor B; NK, natural killer; NK-T, natural killer T; OxLDL, oxidized low density lipoprotein; RAG, recombination-activating gene; SAA, serum amyloid A; TCR, T-cell receptor; TGF, transforming growth factor; Th cell, T-helper cell; TNF, tumor necrosis factor

Supplementary key words innate immunity • adaptive immunity • cytokines

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. S. Green, T. Vaisar, S. Pennathur, J. J. Kulstad, A. B. Moore, S. Marcovina, J. Brunzell, R. H. Knopp, X.-Q. Zhao, and J. W. Heinecke Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome Circulation, September 16, 2008; 118(12): 1259 - 1267. [Abstract] [Full Text] [PDF]

				J.-F. Mauger, J. Levesque, M.-E. Paradis, N. Bergeron, A. Tchernof, P. Couture, and B. Lamarche Intravascular Kinetics of C-Reactive Protein and Their Relationships with Features of the Metabolic Syndrome J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3158 - 3164. [Abstract] [Full Text] [PDF]

				K. F. Tacer, D. Kuzman, M. Seliskar, D. Pompon, and D. Rozman TNF-{alpha} interferes with lipid homeostasis and activates acute and proatherogenic processes Physiol Genomics, October 19, 2007; 31(2): 216 - 227. [Abstract] [Full Text] [PDF]

				H. Methe and M. Weis Atherogenesis and inflammation--was Virchow right? Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1823 - 1827. [Full Text] [PDF]

				K. Oda, N. Tanaka, T. Arai, J. Araki, Y. Song, L. Zhang, A. Kuchiba, T. Hosoi, T. Shirasawa, M. Muramatsu, et al. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases Hum. Mol. Genet., March 15, 2007; 16(6): 592 - 599. [Abstract] [Full Text] [PDF]

				P. A. VanderLaan, C. A. Reardon, Y. Sagiv, L. Blachowicz, J. Lukens, M. Nissenbaum, C.-R. Wang, and G. S. Getz Characterization of the Natural Killer T-Cell Response in an Adoptive Transfer Model of Atherosclerosis Am. J. Pathol., March 1, 2007; 170(3): 1100 - 1107. [Abstract] [Full Text] [PDF]